Anavex Life Sciences's market cap is currently $724.94M. The company's EPS TTM is $-0.16; its P/E ratio is ―; Anavex Life Sciences is scheduled to report earnings on August 12, 2025, and the estimated EPS forecast is $-0.14. See an overview of income statement, balance sheet, and cash flow financials.
